Related Experiment Videos
Antigen expression associated with lymph node metastasis in gastric adenocarcinomas
S N Wang1, M Miyauchi, N Koshikawa
1Chiba Cancer Center Research Institute, Japan.
Pathology International
|December 1, 1994
Summary
Urokinase-type plasminogen activator (u-PA) and nucleobindin (Nuc) expression are higher in gastric adenocarcinomas with lymph node metastasis. Immunohistochemistry for u-PA and Nuc may predict metastasis potential in stomach cancer.
Area of Science:
- Oncology
- Molecular Biology
- Pathology
Background:
- Gastric adenocarcinomas exhibit variable metastatic potential.
- Identifying biomarkers for lymph node metastasis is crucial for prognosis and treatment.
Purpose of the Study:
- To investigate the expression of urokinase-type plasminogen activator (u-PA) and nucleobindin (Nuc) in gastric adenocarcinomas.
- To determine the correlation between u-PA and Nuc expression and lymph node metastasis.
Main Methods:
- Immunohistochemical analysis of 100 gastric adenocarcinomas (50 with and 50 without lymph node metastasis).
- Assessed reactivity for u-PA, Lex related 4C9 antigen, Jun, and Nuc.
Main Results:
- Higher positivity rates for u-PA (82% vs 52%) and Nuc (56% vs 10%) were observed in tumors with lymph node metastasis compared to those without.
- Significant correlations were found between u-PA expression and Nuc expression, infiltrative growth, invasion depth, and lymphatic invasion.
- Nuc expression correlated significantly with Jun expression, invasion depth, and lymphatic invasion.
Conclusions:
- Elevated expression of u-PA and Nuc in gastric tumor cells is associated with lymph node metastasis.
- Immunohistochemical detection of u-PA and Nuc may serve as valuable indicators for predicting the metastatic potential of gastric adenocarcinomas.